Gravar-mail: GEMCITABINE, FLUDARABINE AND MELPHALAN AS A NOVEL REDUCED-INTENSITY CONDITIONING REGIMEN FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED AND REFRACTORY HODGKIN LYMPHOMA